In the quest for new antibiotics, what are the pharmaceutical companies trying to do? What criteria would you use to judge whether to develop a new antibiotic? What is the attraction of sticking with known antibiotics and trying to modify their structures rather than looking for new antibiotic targets?
Already registered? Login
Not Account? Sign up
Enter your email address to reset your password
Back to Login? Click here